Home
Disease Areas

Powering Innovation and Protecting Health Through a Diversified, Strategic Pipeline

Our team is focused on what we do best

At Novavax, we are focused on driving innovation with our technology platform via R&D. 

We operate with strategic agility, through programs that can quickly demonstrate proof-of-concept, address complex unmet needs and offer meaningful commercial opportunity.

We leverage R&D to strengthen our platform technology, expand its utility within and potentially beyond infectious disease, and driving further proof points and data to develop new assets with which we can partner.

Disease Areas

Specific to our work developing new assets, we’re addressing some of the world’s most significant health challenges. Learn about each disease area, including unmet needs and our unique approach to vaccine development to impact the lives of people around the globe.

Clostridioides Difficile Colitis
Learn more
COVID-19 and Influenza
Learn more
Malaria
Learn more
Respiratory Syncytial Virus
Learn more
Shingles
Learn more

Pipeline

With cutting-edge technology and deep R&D expertise, our platform is fueling innovation in infectious diseases, with the potential to expand in the future.

View our pipeline

Products

Our technology platform has been instrumental in the creation of innovative vaccines for COVID-19 and malaria, which have been deployed to millions of people in need.

Learn more